A global phase 2 trial found that giving durvalumab plus chemotherapy before surgery enabled most patients with resectable or borderline resectable non-small-cell lung cancer to have an operation, with encouraging pathological complete response rates and no new safety concerns.
You must log in or register to comment.
Another “encouraging” phase 2 with a fancy name. Ping me when it reads out at phase 3.
Phase 2 means a small trial, and “most” usually means the drug works until the insurers start asking questions.
Sure, because nothing says “affordable” like a $12,000 infusion before the surgery you still have to pay for.
Phase 2, small n, and somehow this is news. Shocking: drugs shrink tumors.
